News

News
Partner news

Leyden Labs Licenses Pan-Influenza Antibody from Janssen

Read full story
Partner news

The UK’s largest ever health research programme to transform the prevention, detection and treatment of diseases

Read full story
Partner news

TRexBio Announces Collaboration with Janssen to Discover Novel Targets for Immunology and Inflammation

Read full story
Partner news

i2O Therapeutics Announces Research Collaboration and Option Agreement with Janssen to Investigate the Oral Delivery of Macromolecules

Read full story
Partner news

SRI International announces collaboration agreement with Janssen

Read full story
Partner news

Genocea Biosciences Provides Corporate Update

Read full story
Partner news

£10 million research collaboration to detect lung cancer earlier

Read full story
Partner news

Revitope Oncology Announces Strategic Collaboration with Janssen to Leverage its Unique T Cell Engager Platform

Read full story
Partner news

Morphic Expands Research and Development Collaboration with Janssen Through Third Integrin Program

Read full story
Partner news

BlackThorn Therapeutics Advances Phase 2 Clinical Development for Selective KOR Antagonist, BTRX-140, in Neuropsychiatric Disorders

Read full story
Partner news

Concerto HealthAI Establishes Real-World Data and AI Collaboration with Janssen

Read full story
Partner news

Exonate Announces Collaboration with Janssen to develop a new eye drop for the treatment of retinal vascular diseases including wet age-related macular degeneration (AMD) and diabetic macular oedema (DMO)

Read full story
Partner news

Memebox Closes $35 Million Financing to Fuel Innovation and Accelerate Company Growth

Read full story
Partner news

Philogen Announces Drug Discovery Collaboration With Johnson & Johnson Innovation

Read full story
Partner news

Ribon Therapeutics Raises $65 Million to Advance Pipeline of Novel Therapeutics Targeting Cellular Stress Pathways for Cancer

Read full story